Pendulum is committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases. Our targeted formulations of natural bacterial strains help to rebalance the microbiome which restores and improves one’s health. Pendulum Glucose Control is a probiotic medical food designed to help minimize blood sugar spikes and lower A1C in people with type 2 diabetes compared to placebo.
Founded and based in San Francisco, we’re a team of scientists, doctors, and innovators. But more than that, we’re a team with passion and purpose. Driven by finding improvements to managing chronic illnesses through the microbiome, Pendulum is empowering people with groundbreaking products and tools to achieve long-term health. We’re starting with type 2 diabetes and a new, scientifically anchored approach that starts inside the gut. A new reality is possible for those affected by type 2 diabetes. Our team takes pride in pioneering revolutionary solutions that people deserve to reclaim control of their health.
Total Funding: $111.2 M
Funding Stage: Series C
Business Stage: Scaling Up
Market: B2C
Company Size: 51 to 100
Founded: 2013
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Pendulum Therapeutics
Senior Data Scientist, R&D
San Francisco, California
Lead Data Scientist, R and D
San Francisco, California
Quality Engineer
San Francisco, California
QC Technician I
San Francisco, California
QC Analyst
San Francisco, California
